Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 1997

View Archived Issues

Highlights of the 7th INWIN

Squalene synthase inhibitors from Takeda

Anti-H. pylori agents disclosed by Roussel Morishita

Orthosomycins discovered by Schering-Plough

Lilly describes new agents for postmenopausal syndrome

Chem. Pharm. Forschungs-Gesellschaft describes COX-2 inhibitors

MAO-A and/or MAO-B inhibitors described by Synthelabo

EAA antagonists reported by Pharmacia & Upjohn

5-HT reuptake inhibitors disclosed by NeuroSearch

Pyrimidine derivatives from Roche for psychotic disorders

Unfavorable phase III results of Bay-x-1351 reported

Potent, nonpeptide ECE-1/NEP inhibitor discovered by Novartis

Roche will acquire Boehringer Mannheim Group

Bexxar as first-line therapy for non-Hodgkin's lymphoma

Pfizer sponsors large cardiovascular trial in U.K. and Scandinavia

Panretin in AIDS-related Kaposi's sarcoma

MC-1288 + ciclosporin for allograft rejection

AMPA receptor antagonist YM-90K for acute ischemic stroke

Oral Kytril as effective as i.v. ondansetron for emesis

Xanomeline improves cognitive function and behavior in AD

Y-26763 protects against ischemia/reperfusion injury in dog model

Promising data from pivotal trials of Actiq reported at ASCO

ETA antagonist effective against neointima formation in rabbit model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...